Search research articles
Contact Us
Filters
Showing results (151-160 of 352) with videos related to
Page
of 36
Sort By:
Journal of Crohn'S & Colitis
|
October 19, 2021
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's Disease
Neeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
Clinical and Translational Gastroenterology
|
August 18, 2023
Mirikizumab-Induced Transcriptome Changes in Ulcerative Colitis Patient Biopsies at Week 12 Are Maintained Through Week 52
Travis Johnson, Boyd Steere, Pengyue Zhang, et al.
Gut
|
March 26, 2021
Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD)
Neeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
The American Journal of Gastroenterology
|
December 17, 2009
The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery
Pavol Papay, Walter Reinisch, Elien Ho, et al.
Orvosi Hetilap
|
August 24, 2004
[NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study]
László Lakatos, Péter László Lakatos, Claudia Willheim-Polli, et al.
The American Journal of Gastroenterology
|
March 29, 2008
NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease
Sieglinde Angelberger, Walter Reinisch, Clemens Dejaco, et al.
Clinical Drug Investigation
|
April 2, 2023
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial
Geert D'Haens, Walter Reinisch, Stefan Schreiber, et al.
Journal of Crohn'S & Colitis
|
May 28, 2013
Renal insufficiency in IBD--prevalence and possible pathogenetic aspects
Christian Primas, Gottfried Novacek, Karin Schweiger, et al.
The American Journal of Medicine
|
May 8, 2012
High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease
Pavol Papay, Klaus Hackner, Harald Vogelsang, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
May 13, 2017
Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents
Walter Reinisch, Jørgen Jahnsen, Stefan Schreiber, et al.
Page
of 36
Search research articles
Search
Showing results (151-160 of 352) with videos related to
Sort By:
Page
of 36
Journal of Crohn'S & Colitis
|
October 19, 2021
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's Disease
Neeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
Clinical and Translational Gastroenterology
|
August 18, 2023
Mirikizumab-Induced Transcriptome Changes in Ulcerative Colitis Patient Biopsies at Week 12 Are Maintained Through Week 52
Travis Johnson, Boyd Steere, Pengyue Zhang, et al.
Gut
|
March 26, 2021
Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD)
Neeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
The American Journal of Gastroenterology
|
December 17, 2009
The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery
Pavol Papay, Walter Reinisch, Elien Ho, et al.
Orvosi Hetilap
|
August 24, 2004
[NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study]
László Lakatos, Péter László Lakatos, Claudia Willheim-Polli, et al.
The American Journal of Gastroenterology
|
March 29, 2008
NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease
Sieglinde Angelberger, Walter Reinisch, Clemens Dejaco, et al.
Clinical Drug Investigation
|
April 2, 2023
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial
Geert D'Haens, Walter Reinisch, Stefan Schreiber, et al.
Journal of Crohn'S & Colitis
|
May 28, 2013
Renal insufficiency in IBD--prevalence and possible pathogenetic aspects
Christian Primas, Gottfried Novacek, Karin Schweiger, et al.
The American Journal of Medicine
|
May 8, 2012
High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease
Pavol Papay, Klaus Hackner, Harald Vogelsang, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
May 13, 2017
Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents
Walter Reinisch, Jørgen Jahnsen, Stefan Schreiber, et al.
Page
of 36